Abstract

Volumetric-modulated arc therapy (VMAT) is a relatively new therapy technique in which treatment is delivered using a cone beam that rotates around the patient. The radiation is delivered in a continuous gantry rotation while the cone beam is modulated by the intertwining of dynamic multileaf collimators (MLCs). Studies of VMAT plans have shown reduction in the treatment delivery time and monitor units (MU) comparable to IMRT plans improving major comfort to the patient and reducing uncertainties associated with patient movement during treatment. The treatment using VMAT minimizes the biological effects of radiation to critical structures near to the target volumes and produces excellent dose distributions. The dosimetry of ionizing radiation is essential for the radiological protection programs for quality assurance and licensing of equipment. For radiation oncology a quality assurance program is essentially to maintain the quality of patient care. As the VMAT is a new technique of radiation therapy it is important to optimize quality assurance mechanisms to ensure that tests are performed in order to preserve the patient and the equipment. This paper aims to determinate the dose distribution in the target volume (tumor to be treated) and the scattered dose distribution in the risk organs for VMAT technique comparing data given by the planning system and thermoluminescent (TL) response.

Highlights

  • In the scenery of radiation therapy, a new method of treatment, volumetric modulated arc therapy (VMAT) has been responsible to bring benefits and to allow a lower toxicity in the treatment of patients

  • This paper aims to determinate the dose distribution in the target volume and the scattered dose distribution in the risk organs for Volumetric-modulated arc therapy (VMAT) technique comparing data given by the planning system and thermoluminescent (TL) response

  • Studies comparing VMAT and IMRT plans have presented that VMAT minimizes treatment delivery time, so reducing uncertainties associated with patient movement during treatment

Read more

Summary

Introduction

In the scenery of radiation therapy, a new method of treatment, volumetric modulated arc therapy (VMAT) has been responsible to bring benefits and to allow a lower toxicity in the treatment of patients. This treatment minimizes the radiation dose to the healthy tissues and escalates the dose to the target volume (tumor) (Hall, 1998; Mundt, 2005; Bortfeld, 2006). All components that are involved in the process of treatment planning and dose delivery have to be verified to guarantee the quality assurance This process is essential to maintain the integrity of treatment and therapy equipment. To guarantee that the services accord the highest clinical standards, each institution should invest in a quality assurance program for treatment planning and dose absorbed (Palta et al, 2008; Hancock, 2008) .This paper aims to determinate the dose distribution in the target volume (tumor to be treated) and the scattered dose distribution in the risk organs for VMAT technique comparing data given by the planning system and thermoluminescent (TL) response

Objectives
Methods
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call